Renal Scan: DTPA
Dynamic renal scintigraphy with technetium-99m diethylenetriaminepentaacetic acid (DTPA, pentetate) measures the filtration function of each kidney. DTPA is filtered by the glomeruli and neither secreted nor reabsorbed by the tubules, and about 20% is extracted at each pass.
The uptake in the first 2 to 3 minutes reflects glomerular filtration, and the washout reflects drainage.
Adults receive 100 to 300 MBq by bolus injection, and children a weight based dose with a minimum of about 20 MBq. The camera is placed behind the patient (in front for a transplant or pelvic kidney), and images are collected from the time of injection.
A flow phase of 1 to 2 seconds in each frame for the first minute is followed by frames of 15 to 20 seconds for 20 to 30 minutes.
The study gives perfusion curves, the time to peak, the washout curve (renogram), the relative function of each kidney, and the glomerular filtration rate.
Furosemide (20 to 40 mg intravenously in adults, 0.5 to 1 mg for each kg in children) is added when obstruction is the question. Captopril is added for suspected renovascular hypertension. The effective dose is about 1 to 2 mSv.
Chronic kidney disease affects about 10% of adults. Obstructive uropathy is a common and reversible cause of kidney failure, and renovascular disease accounts for 1 to 5% of hypertension.
DTPA is the preferred tracer when an absolute filtration rate is needed with the images, and the split function is accurate to within about 5 points when kidney function is reasonable.
Indications.
- Relative function of each kidney: before nephrectomy or pyeloplasty, in living donor assessment, and in follow up of reflux or obstruction.
- Obstruction at the pelvi ureteric junction or ureter (with a diuretic).
- Glomerular filtration rate, absolute and for each kidney, when plasma clearance methods are not available.
- Renal transplant: perfusion, acute tubular necrosis, rejection, urine leak, vascular occlusion and lymphocele.
- Renovascular hypertension: study before and after an ACE inhibitor.
- Renal trauma: perfusion, urine leak and devascularisation.
- Differentiating obstruction from acute tubular necrosis in acute kidney injury.
- Function of an ectopic, horseshoe or duplex kidney.
- Function after pyeloplasty or stenting.
- Indirect radionuclide cystography for reflux in children able to void on request.
Contraindications and precautions.
- Pregnancy: avoid unless essential. Breast feeding: usually no interruption, or a brief one.
- The patient is well hydrated (500 mL of water, or 10 mL for each kg in a child, 30 to 60 minutes before). Dehydration reduces the washout and may mimic obstruction.
- The patient empties the bladder before the study. A catheter is used in children, in retention, in reflux studies and in high pressure bladders.
- ACE inhibitor challenge: withhold ACE inhibitors for 3 to 7 days and diuretics for 2 to 3 days. Caution in bilateral renal artery stenosis or a solitary kidney, because of acute renal failure.
- Furosemide: caution in allergy to sulphonamides, in hypovolaemia and in severe hypokalaemia.
- Blood pressure is monitored after captopril. A fall in blood pressure of 20 mmHg or more is common and can distort the images.
- Children may need feeding, swaddling or sedation.
Preparation and technique.
The patient lies supine or sits against the camera. The field includes both kidneys, the aorta and the bladder, or the iliac fossa for a transplant. The tracer is injected as a tight bolus through a good vein, and a poor bolus makes perfusion and uptake curves unreliable.
Regions are drawn around each kidney and an adjacent background. Relative function is calculated from the uptake in the 1 to 2 or 2 to 3 minutes after the tracer reaches the kidney, with background subtraction.
The glomerular filtration rate is estimated from the uptake, corrected for the depth of each kidney, or from plasma samples.
Diuretic timing differs between centres. Furosemide may be given at the start of the study, 15 to 20 minutes into the study when the collecting system is full, or 20 minutes before the tracer.
Imaging continues for a further 20 minutes, and the patient may stand and void before the final images.













